Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas G Graeber

Showing results (61-70 of 132) with videos related to

Pageof 14
Sort By:
Biorxiv : the Preprint Server for Biology|March 3, 2025
Defined cellular reprogramming of androgen receptor-active prostate cancer to neuroendocrine prostate cancerShan Li, Kai Song, Huiyun Sun, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2018
Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancerJohn K Lee, Nathanael J Bangayan, Timothy Chai, et al.
Cancer Cell|April 17, 2018
Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative StressJennifer Tsoi, Lidia Robert, Kim Paraiso, et al.
The Journal of Clinical Investigation|March 5, 2013
Host immunity contributes to the anti-melanoma activity of BRAF inhibitorsDeborah A Knight, Shin Foong Ngiow, Ming Li, et al.
Microbiome|January 24, 2014
Integrative analysis of the microbiome and metabolome of the human intestinal mucosal surface reveals exquisite inter-relationshipsIan H McHardy, Maryam Goudarzi, Maomeng Tong, et al.
Scientific Reports|September 6, 2019
Hyperoxia but not AOX expression mitigates pathological cardiac remodeling in a mouse model of inflammatory cardiomyopathyPraveen K Dhandapani, Isabel M Begines-Moreno, Gloria Brea-Calvo, et al.
Cancer Immunology Research|September 4, 2016
Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T CellsBlanca Homet Moreno, Jesse M Zaretsky, Angel Garcia-Diaz, et al.
Cancers|September 14, 2024
Targeting Asparagine Metabolism in Well-Differentiated/Dedifferentiated LiposarcomaKyle D Klingbeil, Blake R Wilde, Danielle S Graham, et al.
Nature Medicine|March 27, 2012
NOD2 triggers an interleukin-32-dependent human dendritic cell program in leprosyMirjam Schenk, Stephan R Krutzik, Peter A Sieling, et al.
The ISME Journal|May 1, 2014
Reprograming of gut microbiome energy metabolism by the FUT2 Crohn's disease risk polymorphismMaomeng Tong, Ian McHardy, Paul Ruegger, et al.
Pageof 14

Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
Biorxiv : the Preprint Server for Biology|March 3, 2025
Defined cellular reprogramming of androgen receptor-active prostate cancer to neuroendocrine prostate cancerShan Li, Kai Song, Huiyun Sun, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2018
Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancerJohn K Lee, Nathanael J Bangayan, Timothy Chai, et al.
Cancer Cell|April 17, 2018
Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative StressJennifer Tsoi, Lidia Robert, Kim Paraiso, et al.
The Journal of Clinical Investigation|March 5, 2013
Host immunity contributes to the anti-melanoma activity of BRAF inhibitorsDeborah A Knight, Shin Foong Ngiow, Ming Li, et al.
Microbiome|January 24, 2014
Integrative analysis of the microbiome and metabolome of the human intestinal mucosal surface reveals exquisite inter-relationshipsIan H McHardy, Maryam Goudarzi, Maomeng Tong, et al.
Scientific Reports|September 6, 2019
Hyperoxia but not AOX expression mitigates pathological cardiac remodeling in a mouse model of inflammatory cardiomyopathyPraveen K Dhandapani, Isabel M Begines-Moreno, Gloria Brea-Calvo, et al.
Cancer Immunology Research|September 4, 2016
Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T CellsBlanca Homet Moreno, Jesse M Zaretsky, Angel Garcia-Diaz, et al.
Cancers|September 14, 2024
Targeting Asparagine Metabolism in Well-Differentiated/Dedifferentiated LiposarcomaKyle D Klingbeil, Blake R Wilde, Danielle S Graham, et al.
Nature Medicine|March 27, 2012
NOD2 triggers an interleukin-32-dependent human dendritic cell program in leprosyMirjam Schenk, Stephan R Krutzik, Peter A Sieling, et al.
The ISME Journal|May 1, 2014
Reprograming of gut microbiome energy metabolism by the FUT2 Crohn's disease risk polymorphismMaomeng Tong, Ian McHardy, Paul Ruegger, et al.
Pageof 14